Hı̇pertansı̇yon Hastalarında Mobı̇l Aplı̇kasyon Kullanımının Tedavı̇ Başarısı ve İ̇laç Uyuncu Üzerı̇ne Olan Etkı̇sı̇nı̇n Değerlendı̇rı̇lmesı̇


Kaşkal M., Şen S., Üresin A. Y.

6th International Medicine and Health Sciences Congress, Ankara(online), Ankara, Türkiye, 10 - 11 Nisan 2021, ss.91-99

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Basıldığı Şehir: Ankara
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.91-99
  • Marmara Üniversitesi Adresli: Evet

Özet

Objectıve: One of the most important factors affecting the prognosis of hypertension disease is the patients' adherence to drug therapy. In our study, it was aimed to show the effect of mobile phone application use on drug adherence.

Patıents And Methods: 50 hypertensive patients were included in the study. The 8-question Morisky Drug Adherence Scale (MMAS-8) was applied to evaluate the drug adherence of the patients. Mobile phone application was loaded and re-evaluated with MMAS-8 after 8 weeks, and the effect of the application on patients' drug adherence and blood pressure was observed.

Results: The difference between the patients' systolic blood pressure (SBP) (p <0.001), diastolic blood pressure (DBP) (p <0.05), drug adherence (p = 0.001) was found significant before and after the use of mobile phone application. Before and after application use in geriatric patients, the mean difference between drug adherence (p= 0.006) and SBP(p= 0.016) are significant. The difference was found statistically significant when the drug adherence were evaluated in polypharmacy and non-polypharmacy patients. (p= 0,015)

Conclusion: In the study, with the use of mobile phone application, an increase in drug adherence and a decrease in SBP and DBP was observed which is similar with the data in the literature. It is interesting to see that there is a significant improvement in drug adherence and SBP values after the application, especially in geriatric patients and polypharmacy patients. We think that, especially in polypharmacy patients and geriatric patient groups, mobile application usage will improve drug follow-up and patient participation in treatment of chronic diseases such as hypertension.